Amitabh Thacoor
Congenital Heart Disease, Vol.12, No.4, pp. 430-434, 2017, DOI:10.1111/chd.12467
Abstract Marfan syndrome is a multisystemic genetic condition affecting connective tissue. It carries a
reduced life expectancy, largely dependent on cardiovascular complications. More common cardiac
manifestations such as aortic dissection and aortic valve incompetence have been widely documented in the literature. Mitral valve prolapse (MVP), however, has remained poorly documented.
This article aims at exploring the existing literature on the pathophysiology and diagnosis of MVP
in patients with Marfan syndrome, defining its current management and outlining the future developments surrounding it. More >